Results of EEG Biofeedback Therapy on 24 subjects who were taking Ritalin® (methylphenidate) :
Symptoms reduced after EEG Biofeedback therapy, showing that the medication became more effective: 33%
Amount of medication taken decreased after EEG Biofeedback therapy: 46%
Eliminated medication altogether after EEG Biofeedback therapy: 21%
*Information from Alhambra, M.A., et al, (1995). EEG Biofeedback:
A new treatment option for ADD/ADHD. Journal of Neurotherapy, 1995, 1 (2), 39-43.
The Use of A/V Stimulation in
Improving Performance of Children with ADHD
by Larry Micheletti, LMSW-ACP, BCIA-C
Larry Micheletti, LMSW-ACP, BCIA-C
Summary of Doctoral Dissertation at www.bioedtech.com/research
STUDY SITE : University of Texas Medical Branch at Galveston
PURPOSE :
The study compared the effectiveness of standard treatment for ADHD using stimulant medications (Ritalin® & Adderall®) to the effectiveness of Audio/Visual Stimulation (AVS) alone or to the effectiveness of a combination of medication and AVS treatment. The 99 children in this controlled study all had the diagnosis of ADHD.
Four separate groups were compared:
1. AVS Group
2. AVS/Stimulant Medication Group
3. Stimulant Medication Group
4. Self-selected Comparison Group
MEASUREMENT OF CHANGES :
Standard evaluations of achievements measured the cognitive functioning levels of all the participants in the study. These evaluation instruments included the Peabody Picture Vocabulary Test (PPVT), Raven Progressive Matrices (Raven’s), and the Wide Range Achievement Test (WRAT-R).
The Attention Deficit Disorder Evaluation Scale (ADDES) and the Intermediate Visual and Auditory (IVA) Continuous Performance Test measured behavioral changes. The study compared the effectiveness of standard treatment for ADHD with stimulant medication (Ritalin® & Adderall®) with that of AVS only and with the combination of medication and AVS treatment with a self-selected no treatment comparison group.
RESULTS
: Both the AVS group and the stimulant medication group showed significant improvements in cognitive and behavioral areas. The combined AVS and stimulant medication group showed the greatest improvements. The stimulant medication group showed less change when compared to the AVS and AVS/Stimulant groups. The self-selected comparison group or control indicated no change on any measurement. Further study is indicated to explore and replicate the findings in this study.
The Professionals at Smarter Way recommend that you also check out the explanations and descriptions found on the product page for more information.
Caution :
People who should avoid this special LSI usually include people with serious, chronic effects of head injuries, psychiatric illness, or seizure activity. Always consult with your primary care physician (PCP) before using any of the products from this or any other website.
Disclaimer :
The professionals at Smarter Way personally use and recommend the products available on this website and offer them to their clients as deemed appropriate. You should always consult your primary care physician (PCP) to determine what treatment is right for you. All products and resources used on this site are provided for educational purposes only and are not intended as medical advise or as a substitution for treatment or consultation with your primary care physician (PCP).